Low Dose Ketamine (LDK) Versus Morphine for Acute Pain Control in the Emergency Department (NCT01538745) | Clinical Trial Compass
CompletedPhase 4
Low Dose Ketamine (LDK) Versus Morphine for Acute Pain Control in the Emergency Department
United States45 participantsStarted 2012-02
Plain-language summary
The purpose of this study is to compare the safety and effectiveness of intravenous low dose ketamine (LDK) to the industry standard of morphine (MOR) in regards to controlling acute pain in the emergency department.
Both LDK and morphine have side effects. The amount and character of these side effects will be compared. Additionally, the degree of sedation or agitation will be specifically measured. The aim of this current study is to make this comparison and shift the evidence for LDK use from the anecdotal to the scientific.
Who can participate
Age range
18 Years – 59 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients age 18-59 who present to the Brooke Army Medical Center Emergency Department with acute (less than 10 days) abdominal pain, flank/lumbar back pain and or/pain to the extremities, and of sufficient severity in the judgement of the ED treating physician or PA to warrant use of intravenous opioids
Exclusion Criteria:
* Poor vital sign stability hypoxia: Sats\<95% hypotension: SBP\<90 hypertension: SBP\>180 heart rate: \<50 or \>120 respiratory rate: \<10 or \>30
* Altered mental status or intoxication
* Patient is unwilling to participate or provide informed consent
* History of chronic pain or pain syndrome with concurrent opioid medication use
* fibromyalgia
* Patient has received opioids and/or tramadol in the past 4 hours
* Prescription pain medication use (to exclude muscle relaxants, acetaminophen or NSAIDs including toradol) in the past 4 hours
* Allergy to morphine or ketamine
* Sole provider status
* Adverse reaction to morphine or ketamine in the past
* Patients, who in the opinion of the triage nurse, require immediate analgesic relief
* Patient is female of child-bearing age and unable to provide urine or serum for HCG analysis in triage
* Pregnancy or breast feeding
* Presence of oxygen dependent pulmonary disease, liver cirrhosis or Renal disease requiring dialysis. (as assessed by electronic chart review)
* Presence of Ischemic heart disease, heart failure or unstable dysrhythmias (as assessed by electronic chart review)
* Presenc…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Maximal Change in Numerical Rating Scale (NRS) Pain Score From Baseline NRS Pain Score
Timeframe: 5,10,20,40,60,80,100,120 minutes post dose